Capital Markets Alliance challenges CFTC approval of single-stock perpetual derivatives, claiming exclusive SEC jurisdiction — and a New York judge has already flagged the case’s merits.
MoneyTurkey Options Desk | 5 November 2026
Key points
- The Capital Markets Alliance, backed by Cboe, Citadel Securities and Healthy Markets, sued to vacate CFTC approvals of perpetual derivatives on US stocks and ETFs.
- Judge Caproni denied emergency relief but said the balance of equities and public interest favour the alliance, with government response due 6 November and CMA reply due 10 November.
The Capital Markets Alliance sued the Commodity Futures Trading Commission this week to overturn its approval of single-stock perpetual derivatives. The group argues the products are security-based swaps under exclusive Securities and Exchange Commission jurisdiction. It says the CFTC offered no explanation for the approvals and failed to weigh impacts on investors and securities markets.
What happened
The alliance filed in the US District Court for the Southern District of New York. It seeks to vacate the approvals, declare the products security-based swaps, and bar the CFTC from giving them effect while the case is pending.
Judge Caproni denied the alliance’s request for a temporary restraining order, finding the harms cited did not warrant emergency relief. She also indicated the alliance is likely to succeed on the merits, noting that the CFTC’s actions look like a major disruption to the equities market and that the public would be served by preventing that disruption before it occurs.
The government must respond to the motion by Friday 6 November. The alliance’s reply is due Tuesday 10 November.
Regulatory arguments
The alliance contends the CFTC violated the Administrative Procedure Act by approving the products without acknowledging their status as swaps, and without reasonably considering investor and securities-market impacts.
Alliance secretary Adam Ford said coherent regulatory oversight underpins the global standing of US securities markets, and that a hasty rollout of products that circumvent established frameworks erodes investor protection.
Cboe chief executive Craig Donohue said single-stock perpetual derivatives should remain on registered securities platforms under US securities-law protections. He argued that letting securities products trade outside that framework creates regulatory arbitrage and bypasses federal and state law.
Why it matters
For options and listed-derivatives desks, the fight is about which rulebook governs perpetual contracts on US stocks and ETFs — CFTC commodity rules or SEC securities rules. Venue choice, margin, disclosure and who can list the products all hang on that line.
The suit tests the boundary between the two agencies on novel equity-linked derivatives. Caproni’s comments put market-structure stakes on the record even as she refused an emergency halt.
The briefing calendar this week will show how hard the government presses to keep the CFTC pathway open before any ruling on the motion to vacate.
What to watch
- Government response due 6 November
- Alliance reply due 10 November
- Any further court order on the motion to vacate the approvals
Related on MoneyTurkey
- Cboe Index Options Hit 6.9M ADV Record as SPX 0DTE Sets Pace
- Stryker Jumps With Medtech After Midterms; Options Screens Flag a Deep $560 Put
For information only. Not investment advice.
Sources
- The TRADE: Cboe and Citadel Securities-backed industry body contests CFTC green light for single-stock perpetual derivatives
- Reuters: Trading single-stock perps can begin, US regulator says
- Yahoo Finance: Why a Cboe, Citadel backed group is suing CFTC regulators
- The Crypto Times: Cboe-Backed Group Seeks to Overturn CFTC’s Stock Perpetuals Approval
